Attention A T users. To access the menus on this page please perform the following steps.
1. Please switch auto forms mode to off.
2. Hit enter to expand a main menu option (Health, Benefits, etc).
3. To enter and activate the submenu links, hit the down arrow.
You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.
Locator
Contact
Search
Search
VA »
Health Care »
Center for Health Equity Research and Promotion
» Investigators
»
Daniel E. Forman, MD, FAHA, FACC
Center for Health Equity Research and Promotion
Menu
Daniel E. Forman, MD, FAHA, FACC
CHERP COIN Investigator
Professor of Medicine, University of Pittsburgh Chair
Emerging Therapeutics, and Associate Director, University of Pittsburgh Director of Translational Research,
Director of Research, VA Pittsburgh Healthcare System
Profile
Dr. Daniel Forman is a Professor of Medicine at the University of Pittsburgh in the Divisions of Cardiology and Geriatrics. He has faculty appointments at the University of Pittsburgh Medical Center (UPMC) and the VA Pittsburgh Health System (VAPHS). At UPMC, he is Chair of Geriatric Cardiology and Associate Director of Translational Research at the University of Pittsburgh's Aging Institute. At the VAPHS, he is the Director of Translational Research of the Pittsburgh Geriatrics Research, Education, and Clinical Center (GRECC) as well as Director of Transitional Care with related leadership as Director of its Cardiac Rehabilitation and Gerofit programs.
| Research Areas |
| Broad thematic focus on improving function of older adults with cardiovascular disease, including elements of multimorbidity, frailty, and polypharmacy, and overcoming disparities of care based on age, frailty, multimorbidity, and sex/socioeconomics (as age tends to includes more women survivors with dwindling socioeconomic assets) |
| Health service research focused on improved administration of cardiac rehabilitation, including study of a coaching model, a transition model, improved exercise prescription, and advancing different models of care (site-based, remote-based, and hybrid combinations) |
| Translational research on specific cellular mechanisms that determine functional attributes in older adults with cardiovascular disease, multimorbidity, and frailty, and the study of novel therapeutics (e.g., nitrite, metformin) to improve them, such that cellular bioenergetics as well as physical function/daily activity are all enhanced |
